The ASPIS Open Symposium happened during the 21st European Society of Toxicology In Vitro (ESTIV) Congress on 24-25 November 2022 in Sitges, Barcelona (Spain), a bi-annual appointment aiming to create a forum of scientists in a unique atmosphere for discussions and knowledge exchange focusing on the development of in vitro and in silico approaches.

During this event, the ASPIS cluster presented the work performed by the three Horizon 2020 projects composing the consortia (ONTOX, PrecisionTOX, and RISKHUNT3R). The objectives of the ASPIS Open Symposium included: 

  • Increasing confidence in and promoting NAM regulatory uptake; 
  • Delineating foreseen ASPIS impact on regulatory issues; 
  • Engaging young researchers and supporting scientific networking; 
  • Facilitating interactions among ASPIS and international stakeholders